Related Experiment Video
Updated: Sep 25, 2025

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
[TAILORED APPROACH TO THE GERIATRIC PATIENT WITH CANCER]
Shlomit Strulov Shachar1, Orly Barak2
1Breast Cancer Unit, The Oncology Division, Tel Aviv Sourasky Medical Center.
Introduction:
Cancer became one of the most common clinical problems in the care of older adults. Cancer is the leading cause of death in Israel. Currently about 50% of cancer diagnoses occur in patients over 65 years of age, but this number is expected to increase to 70% by 2030. This is largely due to the shifting demographics, increasing life expectancy and improvements in the level of mortality from cardiovascular disease. The aging cancer population has an impact across the treatment spectrum from screening decisions, multimodality treatment options, survivorship and quality of life. This paper will review the approach to the principles of geriatric oncology within different treatment modalities.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Survival Analysis
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

